These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Bollerslev J, Møller J, Thomas S, Djøseland O, Christiansen JS. Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710 [Abstract] [Full Text] [Related]
25. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. Bergmann P, Valsamis J, Van Perborgh J, De Schepper J, Van Vliet G. J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302 [Abstract] [Full Text] [Related]
26. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. J Clin Endocrinol Metab; 1994 Aug; 79(2):470-9. PubMed ID: 7519191 [Abstract] [Full Text] [Related]
28. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. Johansson AG, Engström BE, Ljunghall S, Karlsson FA, Burman P. J Clin Endocrinol Metab; 1999 Jun; 84(6):2002-7. PubMed ID: 10372701 [Abstract] [Full Text] [Related]
34. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. Lanes R, Gunczler P, Esaa S, Weisinger JR. Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321 [Abstract] [Full Text] [Related]
35. Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice. Kristensen E, Hallgrímsson B, Morck DW, Boyd SK. Bone; 2010 Aug; 47(2):295-300. PubMed ID: 20399917 [Abstract] [Full Text] [Related]
36. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303 [Abstract] [Full Text] [Related]
37. Growth hormone status during long-term hexarelin therapy. Rahim A, O'Neill PA, Shalet SM. J Clin Endocrinol Metab; 1998 May; 83(5):1644-9. PubMed ID: 9589671 [Abstract] [Full Text] [Related]
38. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG. Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229 [Abstract] [Full Text] [Related]
39. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. Mann DR, Rudman CG, Akinbami MA, Gould KG. J Clin Endocrinol Metab; 1992 Jun; 74(6):1263-9. PubMed ID: 1592869 [Abstract] [Full Text] [Related]
40. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD. J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]